Can CAR-T cells free HIV patients from daily medication?
Disease control
Recruiting now
This early-phase trial tests whether specially engineered immune cells (CAR-T cells) can control HIV in people who stop their regular antiretroviral drugs. 18 participants will receive a single infusion of their own modified cells, with some also getting a mild chemotherapy drug …
Phase: PHASE1, PHASE2 • Sponsor: Steven Deeks • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC